Ashley Cordova
2021
In 2021, Ashley Cordova earned a total compensation of $5.5M as Chief Financial Officer at NovoCure, a 69% increase compared to previous year.
Compensation breakdown
| Option Awards | $1,664,746 |
|---|---|
| Salary | $477,500 |
| Stock Awards | $3,333,248 |
| Other | $8,950 |
| Total | $5,484,444 |
Cordova received $3.3M in stock awards, accounting for 61% of the total pay in 2021.
Cordova also received $1.7M in option awards, $477.5K in salary and $9K in other compensation.
Rankings
In 2021, Ashley Cordova's compensation ranked 2,333rd out of 12,415 executives tracked by ExecPay. In other words, Cordova earned more than 81.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,333 out of 12,415 | 81st |
Division Manufacturing | 914 out of 5,508 | 83rd |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 97 out of 801 | 88th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 62 out of 522 | 88th |
Industry Surgical and Medical Instruments and Apparatus | 41 out of 327 | 88th |
Source: SEC filing on April 25, 2022.
Cordova's colleagues
We found four more compensation records of executives who worked with Ashley Cordova at NovoCure in 2021.